Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4

Nature

Volumn 395, Issue 6698, 1998, Pages 189-194

  Herbein, Georges ^a,b   Mahlknecht, Ulrich ^a   Batliwalla, Franak ^c   Gregersen, Peter ^c   Pappas, Todd ^b   Butler, John ^b   O'Brien, William A ^b   Verdin, Eric ^a,d  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; RECOMBINANT GLYCOPROTEIN GP 120; UNCLASSIFIED DRUG;

ARTICLE; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION;

ANTIGENS, SURFACE; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELLS, CULTURED; CHEMOKINES, CXC; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; RECEPTORS, CXCR4; TROPISM;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032505065     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/26026     Document Type: Article

References (26)

1. + T cells. Science 270, 1811-1815 (1995).
2. + T cells. Immunol. Today. 17, 217-224 (1996).
3. Meyaard, L. et al. Programmed death of T cells in HIV-1 infection. Science 257, 217-219 (1992).
4. Margolick, J. B. et al. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study. Nature Med. 1, 674-680 (1995).
5. + T cell turnover. Science 274, 1543-1547 (1996).
6. + T cell anti-HIV activity. Clin. Immunol. Immunopathol. 73, 80-87 (1994).
7. + donors by cysteine protease inhibitors. J. Immunol. 153, 862-872 (1994).
8. Pakker, N. G. et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nature Med. 4, 208-214 (1998).
9. Herbein, G., Van Lint, C., Lovett, J. L. & Verdin, E. Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes. J. Virol. 72, 660-670 (1998).
10. Wu, M. X., Daley, J. F., Rasmussen, R. A. & Schlossman, S. F. Monocytes are required to prime peripheral blood T cells to undergo apoptosis. Proc. Natl Acad. Sci. USA 92, 1525-1529 (1995).
11. Collin, M., Illei, P., James, W. & Gordon, S. Definition of the range and distribution of human immunodeficiency virus macrophage tropism using PCR-based infectivity measurements. J. Gen. Virol. 75, 1597-1603 (1994).
12. Simmons, G. et al. Primary, synctium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70, 8355-8360 (1996).
13. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877 (1996).
14. Bleul, C. C. et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-833 (1996).
15. Choe, H. et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148 (1996).
16. Doranz, B. J. et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149-1158 (1996).
17. Effros, R. B. & Pawelec, G. Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? Immunol. Today. 18, 450-454 (1997).
18. Heller, R. A., Song, K., Fan, N. & Chang, D. J. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 70, 47-56 (1992).
19. Zheng, L. et al. Induction of apoptosis in mature T cells by tumour-necrosis factor. Nature 377, 348-351 (1995).
20. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450 (1985).
21. Schuitemaker, H. et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66, 1354-1360 (1992).
22. + cell depletion and progression to AIDS. Ann. Intern. Med. 118, 681-688 (1993).
23. Daar, E. S. et al. Sequential determination of viral load and phenotype in human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retrovir. 11, 3-9 (1995).
24. Connor, R. I. & Ho, D. D. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68, 4400-4408 (1994).
25. Phillips, R. E. et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T-cell recognition. Nature 354, 453-459 (1991).
26. Feinberg, M. B. & McLean, A. R. AIDS: decline and fall of immune surveillance? Curr. Biol. 7, R136-R140 (1997).